Patent ID: 8993717
Filing Date: 2015-03-31
Classification: A61K,A61P,C07K

Abstract:
1. A method of treating hematological cancer comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I: wherein, A is an oligopeptide moiety or an oligopeptoid moiety comprising the residues Y Y1 is D-tryptophan or D-tyrosine Y4 is D-phenylalanine or D-tyrosine Y2 is an amino acid residue in the D-configuration or a residue of an amino acid derivative in the D-configuration or is absent; Y3 is an amino acid residue in the D-configuration or a residue of an amino acid derivative in the D-configuration or is absent; X X or derivatives thereof, said derivatives being selected from the group consisting of: and